Question

Difficulty: EasyReproductive Endocrinology and Infertility

A 24-year-old healthy female presents to the clinic reporting an absence of menses for the past six months. She previously had regular 28-day menstrual cycles. She does not take any medications, has no chronic medical conditions, and reports no breast discharge, visual changes, or hot flashes. Physical examination reveals a normal body mass index and normal secondary sexual characteristics. Arrange the following diagnostic steps in the most appropriate chronological sequence for the initial evaluation of this patient's secondary amenorrhea, starting with the most immediate first step.

  1. 1Urine beta-human chorionic gonadotropin (beta-hCG) testing
  2. 2Serum prolactin and thyroid-stimulating hormone (TSH) measurement
  3. 3Progestin withdrawal test
  4. 4Serum follicle-stimulating hormone (FSH) assessment

Answer

The correct sequence is: beta-hCG testing, followed by TSH and prolactin measurement, then a progestin withdrawal test, and finally an FSH assessment.
The algorithm for secondary amenorrhea mandates a logical, cost-effective progression. Pregnancy is ruled out first because it is the most common etiology. Next, easily treatable systemic conditions (thyroid and pituitary adenomas) are evaluated via TSH and prolactin. Once these are excluded, the progestin challenge determines if the ovaries are producing estrogen. Only if estrogen is lacking (no withdrawal bleed) is FSH required to determine if the failure is at the level of the ovary or the brain.

Step-by-Step Solution

1
Exclude pregnancy.
Beta-hCG test is ordered as the first step.
Pregnancy is the most prevalent cause of secondary amenorrhea in women of reproductive age. It must always be ruled out before any other diagnostics or hormonal treatments are initiated.
2
Evaluate for common endocrine disorders.
TSH and prolactin levels are drawn.
Thyroid disorders and hyperprolactinemia are frequent, easily identifiable, and highly treatable causes of secondary amenorrhea that can disrupt the hypothalamic-pituitary-ovarian axis.
3
Assess estrogen status and outflow tract patency.
A progestin withdrawal test (e.g., a 10-day course of medroxyprogesterone acetate) is administered.
Withdrawal bleeding confirms adequate endogenous estrogen production and an intact outflow tract (typical of anovulation/PCOS). Absence of bleeding indicates hypoestrogenism or an anatomic abnormality.
4
Localize the defect if the progestin challenge is negative.
FSH levels are checked.
Measuring FSH distinguishes between an ovarian etiology (hypergonadotropic hypogonadism, high FSH) and a hypothalamic/pituitary etiology (hypogonadotropic hypogonadism, low/normal FSH).

Key Concept

The stepwise evaluation of secondary amenorrhea always begins with a pregnancy test, followed by systemic endocrine screening (TSH/Prolactin), and subsequent anatomic/estrogen evaluation using hormonal challenges and gonadotropin levels.
Rate this question